I wonder if everyone buying $CLDN at this price realizes it could technically be worth $0 next month if the trial is a complete failure?
The Times: CTI BioPharma (CTIC) may announce positive news on a drug or a obligatory bid.
BIOC market cap is over $100 million after the dilution. This is why it only moved .40 on 12 million shares. The warrant holders? Are converting from $1.56 & selling to you. This is a $1.50 stock.
Let's see...they said 401 data mid year & more at ASH. 501 data in Nov. 801 IND this year & that is why they raised the extra cash. My thoughts....cash rich biotech with no debt. Several catalysts into mid & end of year. I like this stock here and I own it around $14.
Says expect data soon, many data points in 2015. Should benefit from January effect of small caps.